• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Neuroscience

brain
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Relyvrio/Albrioza: New Drug for Amyotrophic Lateral Sclerosis Treatment

September 29, 2022September 30, 2022

Amylyx Pharmaceuticals proposed mixture of sodium phenylbutyrate and tauroursodeoxycholic acid for ALS treatment.

gene therapy
Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Skysona: Gene Therapy for Cerebral Adrenoleukodystrophy

September 19, 2022September 19, 2022

A single dose of the elivaldogene autotemcel will cure a deadly disease.

major-depressive-disorder
Posted inNeuroscience, New Drugs, Regulatory

Auvelity: New Antidepressant for Most Severe Depression

August 19, 2022September 8, 2022

Dextromethorphan and bupropion: A powerful drug combination that will help with depression that cannot be treated with standard antidepressants.

brain
Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases

Qalsody: New Drug for Amyotrophic Lateral Sclerosis with SOD1 Mutation

August 2, 2022September 8, 2022

Tofersen and the mixed results of treatment for the deadly neurodegenerative disease.

Alsitek: New Drug for ALS
Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases

Alsitek: New Drug for ALS

June 17, 2022September 8, 2022

Oral masitinib doubles the life in patients with amyotrophic lateral sclerosis.

brain
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Ublyxi: Highly Effective Drug for Multiple Sclerosis

May 31, 2022September 8, 2022

Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.

Brain.
Posted inNeuroscience, New Drugs, Regulatory

Oligomannate: Finally New Drug to Treat Alzheimer’s Disease

April 26, 2022September 8, 2022

Innovative Chinese medicine eliminates gut microbiota dysbiosis, and it helps slow the progression of dementia in Alzheimer’s disease.

Posts navigation

1 2 3 … 5 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News